| (210) | Number of the EPO application | 21722538 |
| (220) | Filing date of the EPO application | 2021.03.19 |
| (80) | EPO patent specification publication (B) | EPB nr. 27/2025, 2025.07.02 |
| (110) | EPO patent number | 4121007 |
| (11) | Number of the document | MD 4121007 T2 |
| (21) | Number of the application | e 2023 0104 |
| (71) | Name(s) of applicant(s), code of the country | EISAI R&D MANAGEMENT CO., LTD., JP; |
| (72) | Name(s) of inventor(s), code of the country | YOSHIDA Nobuo, JP;
SAKURAMOTO Naomi, JP;
SAKAGUCHI Takahisa, JP;
KITO Hirokazu, JP;
OZAWA Takahiro, JP;
JOSHI Anjali, US;
HSU Yung Yueh, US;
SOUILLAC Pierre, US; |
| (73) | Name(s) of owner(s), code of the country | EISAI R&D MANAGEMENT CO., LTD., JP; |
| (54) | Title of the invention | High concentration anti-amyloid beta peptide protofibril antibody formulations and methods of use thereof |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 39/00 (2006.01.01); A61K 47/12 (2006.01.01); A61K 47/18 (2017.01.01); A61K 47/26 (2006.01.01) |
| (52) | Cooperative Patent Classification | A61K 9/0019 (EP); A61K 39/39591 (EP); A61K 47/183 (EP); C07K 16/18 (EP); A61K 47/12 (EP); A61K 47/26 (EP) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2023.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2025.11.30 |
| (30) | Priority | 202062992746 P, 2020.03.20, US; 202063027263 P, 2020.05.19, US |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/IB2021/000155, 2021.03.19 |
| (87) | International publication | WO 2021/186245, 2021.09.23 |